Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 24, 2008

Clinical Data and Affymetrix Sign  Marketing Deal for New Drug Metabolism Service

  • Clinical Data and Affymetrix signed a marketing agreement for Affymetrix’ drug metabolizing enzymes and transporter (DMET) early access solution. Cogenics and Epidauros Biotechnologie, both subsidiaries of Clinical Data, will offer the DMET services on a global basis, with limited exclusivity in Europe.

    The DMET early access solution provides a method for assaying the genetics of drug metabolism, according to Affymetrix.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »